A303-509A-M
- Brand
- Bethyl Laboratories
- Application
- IP
WB
- Storage Conditions
- 2 - 8° C
- Host
- Rabbit
- Conjugation
- Unconjugated
- Immunogen
- between 554 and 604
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide
- Reactivity
- Human
- Target
- ETO
- Shelf Life
- 1 year from date of receipt
- Antibody Type
- Polyclonal
- Alternate Names
- acute myelogenous leukemia 1 translocation 1, cyclin-D related, AML1-MTG8, AML1T1, CBFA2T1, CDR, core-binding factor, runt domain, alpha subunit 2; translocated to, 1, cyclin D-related, Cyclin-D-related protein, eight twenty one protein, ETO, MTG8, myeloid translocation gene on 8q22, protein CBFA2T1, Protein ETO, Protein MTG8, runt related transcription factor 1; translocated to, 1 (cyclin D related), zinc finger MYND domain-containing protein 2, ZMYND2
- Format
- Whole IgG
- Presumed Reactivity
- Based on 100% sequence identity, this antibody is predicted to react with Mouse
- Product Type
- Primary Antibodies
- Product Sub Types
- Primary Antibodies
- UNSPSC
- 12352203
- Western Blot (WB)
- 1:500 - 1:2,500
- Immunoprecipitation (IP)
- 2 - 10 µg/mg lysate
- Target Sentence
- ETO (eight twenty-one protein) is also known as MTG8 (myeloid translocation gene on 8q22) and was identified as part of an 8:21 chromosomal breakpoint in leukemia cells. ETO is encoded by the RUNX1T1 (runt-related transcription factor; translocated to, 1 (cyclin D-related) gene and functions as a transcriptional co-repressor.
- Product Link
- http://www.bethyl.com/product/A303-509A